Rapid saliva testing devices are used for the detection of drugs, alcohol, and other substances in saliva. The global rapid saliva testing devices market is expected to grow at a CAGR of 7.2% during the forecast period from 2021 to 2030. Rapid saliva testing devices are used for workplace drug and alcohol testing, criminal justice drug and alcohol testing, and disease diagnosis. Rapid saliva test kits are available in various formats such as panel salivary test kits, 1-panel salivary test kits, and single-use salivary test kits. Panel salivary test kits have a higher detection limit than 1-panel or single-use salivary test kit formats due to their ability to detect multiple substances simultaneously with one sample collection procedure. Panel Saliva Test Kits segment is expected to dominate the market during the forecast period due to its high accuracy rate in detecting multiple substances simultaneously with one sample collection procedure which makes it suitable for workplace drug and alcohol testing applications where there is a need for accurate results within short time periods.
Rapid saliva testing devices are used to detect the presence of drugs in saliva. The rapid saliva testing devices market is expected to grow at a CAGR of 12.5% from 2017-2022.Factors such as increasing prevalence of drug abuse, growing awareness about the benefits of rapid saliva testing devices, and technological advancements in the field are driving the growth of this market.
Industry Growth Insights published a new data on “Rapid Saliva Testing Devices Market”. The research report is titled “Rapid Saliva Testing Devices Market research by Types (5-Panel Saliva Test Kits, 6-Panel Saliva Test Kits, 10-Panel Saliva Test Kits, 12-Panel Saliva Test Kits, Others), By Applications (Workplace Testing, Criminal Justice Testing, Disease Testing), By Players/Companies Abbott Laboratories, Guangzhou Wondfo Biotech, OraSure Technologies, Quest Diagnostics, Neogen Corporation, Oranoxis Inc, Premier Biotech, Securetec Detektions-Systeme, UCP Biosciences (Chinese Peptide Co), Screen Italia, AccuBioTech, MEDACX Ltd, Oasis Diagnostics”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Rapid Saliva Testing Devices Market Research Report
By Type
5-Panel Saliva Test Kits, 6-Panel Saliva Test Kits, 10-Panel Saliva Test Kits, 12-Panel Saliva Test Kits, Others
By Application
Workplace Testing, Criminal Justice Testing, Disease Testing
By Companies
Abbott Laboratories, Guangzhou Wondfo Biotech, OraSure Technologies, Quest Diagnostics, Neogen Corporation, Oranoxis Inc, Premier Biotech, Securetec Detektions-Systeme, UCP Biosciences (Chinese Peptide Co), Screen Italia, AccuBioTech, MEDACX Ltd, Oasis Diagnostics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Rapid Saliva Testing Devices Market Report Segments:
The global Rapid Saliva Testing Devices market is segmented on the basis of:
Types
5-Panel Saliva Test Kits, 6-Panel Saliva Test Kits, 10-Panel Saliva Test Kits, 12-Panel Saliva Test Kits, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Workplace Testing, Criminal Justice Testing, Disease Testing
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Guangzhou Wondfo Biotech
- OraSure Technologies
- Quest Diagnostics
- Neogen Corporation
- Oranoxis Inc
- Premier Biotech
- Securetec Detektions-Systeme
- UCP Biosciences (Chinese Peptide Co)
- Screen Italia
- AccuBioTech
- MEDACX Ltd
- Oasis Diagnostics
Highlights of The Rapid Saliva Testing Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 5-Panel Saliva Test Kits
- 6-Panel Saliva Test Kits
- 10-Panel Saliva Test Kits
- 12-Panel Saliva Test Kits
- Others
- By Application:
- Workplace Testing
- Criminal Justice Testing
- Disease Testing
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Rapid Saliva Testing Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Rapid saliva testing devices are a type of medical device that is used to measure the level of salivary cortisol in a person's saliva. This device can be used to diagnose conditions such as stress, anxiety, and depression.
Some of the major players in the rapid saliva testing devices market are Abbott Laboratories, Guangzhou Wondfo Biotech, OraSure Technologies, Quest Diagnostics, Neogen Corporation, Oranoxis Inc, Premier Biotech, Securetec Detektions-Systeme, UCP Biosciences (Chinese Peptide Co), Screen Italia, AccuBioTech, MEDACX Ltd, Oasis Diagnostics.
The rapid saliva testing devices market is expected to register a CAGR of 7.2%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Rapid Saliva Testing Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Rapid Saliva Testing Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Rapid Saliva Testing Devices Market - Supply Chain
4.5. Global Rapid Saliva Testing Devices Market Forecast
4.5.1. Rapid Saliva Testing Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Rapid Saliva Testing Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Rapid Saliva Testing Devices Market Absolute $ Opportunity
5. Global Rapid Saliva Testing Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Rapid Saliva Testing Devices Market Size and Volume Forecast by Type
5.3.1. 5-Panel Saliva Test Kits
5.3.2. 6-Panel Saliva Test Kits
5.3.3. 10-Panel Saliva Test Kits
5.3.4. 12-Panel Saliva Test Kits
5.3.5. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Rapid Saliva Testing Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Rapid Saliva Testing Devices Market Size and Volume Forecast by Application
6.3.1. Workplace Testing
6.3.2. Criminal Justice Testing
6.3.3. Disease Testing
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Rapid Saliva Testing Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Rapid Saliva Testing Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Rapid Saliva Testing Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Rapid Saliva Testing Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Rapid Saliva Testing Devices Demand Share Forecast, 2019-2026
9. North America Rapid Saliva Testing Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Rapid Saliva Testing Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Rapid Saliva Testing Devices Market Size and Volume Forecast by Application
9.4.1. Workplace Testing
9.4.2. Criminal Justice Testing
9.4.3. Disease Testing
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Rapid Saliva Testing Devices Market Size and Volume Forecast by Type
9.7.1. 5-Panel Saliva Test Kits
9.7.2. 6-Panel Saliva Test Kits
9.7.3. 10-Panel Saliva Test Kits
9.7.4. 12-Panel Saliva Test Kits
9.7.5. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Rapid Saliva Testing Devices Demand Share Forecast, 2019-2026
10. Latin America Rapid Saliva Testing Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Rapid Saliva Testing Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Rapid Saliva Testing Devices Market Size and Volume Forecast by Application
10.4.1. Workplace Testing
10.4.2. Criminal Justice Testing
10.4.3. Disease Testing
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Rapid Saliva Testing Devices Market Size and Volume Forecast by Type
10.7.1. 5-Panel Saliva Test Kits
10.7.2. 6-Panel Saliva Test Kits
10.7.3. 10-Panel Saliva Test Kits
10.7.4. 12-Panel Saliva Test Kits
10.7.5. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Rapid Saliva Testing Devices Demand Share Forecast, 2019-2026
11. Europe Rapid Saliva Testing Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Rapid Saliva Testing Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Rapid Saliva Testing Devices Market Size and Volume Forecast by Application
11.4.1. Workplace Testing
11.4.2. Criminal Justice Testing
11.4.3. Disease Testing
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Rapid Saliva Testing Devices Market Size and Volume Forecast by Type
11.7.1. 5-Panel Saliva Test Kits
11.7.2. 6-Panel Saliva Test Kits
11.7.3. 10-Panel Saliva Test Kits
11.7.4. 12-Panel Saliva Test Kits
11.7.5. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Rapid Saliva Testing Devices Demand Share, 2019-2026
12. Asia Pacific Rapid Saliva Testing Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Rapid Saliva Testing Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Rapid Saliva Testing Devices Market Size and Volume Forecast by Application
12.4.1. Workplace Testing
12.4.2. Criminal Justice Testing
12.4.3. Disease Testing
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Rapid Saliva Testing Devices Market Size and Volume Forecast by Type
12.7.1. 5-Panel Saliva Test Kits
12.7.2. 6-Panel Saliva Test Kits
12.7.3. 10-Panel Saliva Test Kits
12.7.4. 12-Panel Saliva Test Kits
12.7.5. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Rapid Saliva Testing Devices Demand Share, 2019-2026
13. Middle East & Africa Rapid Saliva Testing Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Rapid Saliva Testing Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Rapid Saliva Testing Devices Market Size and Volume Forecast by Application
13.4.1. Workplace Testing
13.4.2. Criminal Justice Testing
13.4.3. Disease Testing
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Rapid Saliva Testing Devices Market Size and Volume Forecast by Type
13.7.1. 5-Panel Saliva Test Kits
13.7.2. 6-Panel Saliva Test Kits
13.7.3. 10-Panel Saliva Test Kits
13.7.4. 12-Panel Saliva Test Kits
13.7.5. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Rapid Saliva Testing Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Rapid Saliva Testing Devices Market: Market Share Analysis
14.2. Rapid Saliva Testing Devices Distributors and Customers
14.3. Rapid Saliva Testing Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott Laboratories
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Guangzhou Wondfo Biotech
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. OraSure Technologies
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Quest Diagnostics
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Neogen Corporation
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Oranoxis Inc
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Premier Biotech
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Securetec Detektions-Systeme
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. UCP Biosciences (Chinese Peptide Co)
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Screen Italia
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. AccuBioTech
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. MEDACX Ltd
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Oasis Diagnostics
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
